Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Elise M Bekers"'
Autor:
Maisa N. G. van Genderen, Jeroen Kneppers, Anniek Zaalberg, Elise M. Bekers, Andries M. Bergman, Wilbert Zwart, Federica Eduati
Publikováno v:
npj Systems Biology and Applications, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Inhibiting androgen receptor (AR) signaling through androgen deprivation therapy (ADT) reduces prostate cancer (PCa) growth in virtually all patients, but response may be temporary, in which case resistance develops, ultimately leading to le
Externí odkaz:
https://doaj.org/article/ccd027487f2c48e3a61d12b40884f5e4
Autor:
Elise M. Bekers, Astrid Eijkelenboom, Paul Rombout, Peter van Zwam, Suzanne Mol, Emiel Ruijter, Blanca Scheijen, Uta Flucke
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Intramuscular myxoma (IM) is a hypocellular benign soft tissue neoplasm characterized by abundant myxoid stroma and occasional hypercellular areas. These tumors can, especially on biopsy material, be difficult to distinguish from
Externí odkaz:
https://doaj.org/article/07f88e3c24484780a47a1c2e67e4dd72
Autor:
Judith A Stibbe, Hilda A de Barros, Daan G J Linders, Shadhvi S Bhairosingh, Elise M Bekers, Pim J van Leeuwen, Philip S Low, Sumith A Kularatne, Alexander L Vahrmeijer, Jacobus Burggraaf, Henk G van der Poel
Publikováno v:
The Lancet Oncology. 24:457-467
Autor:
Sophie J. M. Reijers, Nicolò Gennaro, Annemarie Bruining, Hester van Boven, Petur Snaebjornsson, Elise M. Bekers, Frits van Coevorden, Astrid N. Scholten, Yvonne Schrage, Winette T. A. van der Graaf, Rick L. M. Haas, Winan J. van Houdt
Publikováno v:
Acta Oncologica. 62:25-32
Autor:
Hilda A. de Barros, Sebastiaan Remmers, Henk B. Luiting, Geert J.L.H. van Leenders, Monique J. Roobol, Elise M. Bekers, Amer Amin, Anne-Maree Haynes, Warick Delprado, Phillip D. Stricker, Henk G. van der Poel, Theodorus H. van der Kwast, Pim J. van Leeuwen
Publikováno v:
de Barros, H A, Remmers, S, Luiting, H B, van Leenders, G J L H, Roobol, M J, Bekers, E M, Amin, A, Haynes, A-M, Delprado, W, Stricker, P D, van der Poel, H G, van der Kwast, T H & van Leeuwen, P J 2022, ' Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection ', Urology, vol. 168, pp. 156-164 . https://doi.org/10.1016/j.urology.2022.04.043
Urology, 168, 156-164. Elsevier Inc.
Urology, 168, 156-164. Elsevier Inc.
Objective: To assess the predictive value of biopsy-identified cribriform carcinoma and/or intraductal carcinoma (CR/IDC) within the Briganti and MSKCC nomograms predicting lymph node metastasis (LNM) in patients with primary prostate cancer (PCa). M
Autor:
Dennie Meijer, Rosemarijn H. Ettema, Pim J. van Leeuwen, Theo H. van der Kwast, Henk G. van der Poel, Maarten L. Donswijk, Daniela E. Oprea‐Lager, Elise M. Bekers, André N. Vis
Publikováno v:
BJU International. 131:330-338
Autor:
Laura E. Stokkel, Huub H. van Rossum, Maaike W. van de Kamp, Thierry N. Boellaard, Elise M. Bekers, Niels F.M. Kok, Bas W.G. van Rhijn, Laura S. Mertens
Publikováno v:
Urologic Oncology: Seminars and Original Investigations, 41(7), 326.e17-326.e24. Elsevier Inc.
Stokkel, L E, van Rossum, H H, van de Kamp, M W, Boellaard, T N, Bekers, E M, Kok, N F M, van Rhijn, B W G & Mertens, L S 2023, ' Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer ', Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 7, pp. 326.e17-326.e24 . https://doi.org/10.1016/j.urolonc.2023.01.018
Stokkel, L E, van Rossum, H H, van de Kamp, M W, Boellaard, T N, Bekers, E M, Kok, N F M, van Rhijn, B W G & Mertens, L S 2023, ' Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer ', Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 7, pp. 326.e17-326.e24 . https://doi.org/10.1016/j.urolonc.2023.01.018
Introduction: Urachal adenocarcinoma (UrAC) is a very rare malignancy with a poor prognosis. The role of preoperative serum tumor markers (STMs) in UrAC is unknown. The aim of this study was to assess the clinical value of elevated STMs including car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff73920b16d2b2f169e6e9c826c59e8
https://research.vumc.nl/en/publications/d2d28123-223e-462c-aee2-5b06a04bd046
https://research.vumc.nl/en/publications/d2d28123-223e-462c-aee2-5b06a04bd046
Autor:
Esther M. K. Wit, Gijs H. KleinJan, Anne-Claire Berrens, Roos van Vliet, Pim J. van Leeuwen, Tessa Buckle, Maarten L. Donswijk, Elise M. Bekers, Fijs W. B. van Leeuwen, Henk G. van der Poel
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Autor:
Wilbert Zwart, Andries M. Bergman, Henk van der Poel, Nathan A. Lack, Lisa M. Butler, Lodewyk F.A. Wessels, Matthew L. Freedman, Amina Zoubeidi, Felix Y. Feng, René H. Medema, Maarten Altelaar, Bogdan Pasaniuc, Ji-Heui Seo, Claudia Giambartolomei, Iris de Rink, Roelof J.C. Kluin, Jeroen de Jong, Dorine C. Hintzen, Anniek Zaalberg, Martin Sjöström, Sylvan C. Baca, Yongsoo Kim, Liesbeth Hoekman, Umut Berkay Altintas, Tunc Morova, Chia-Chi Flora Huang, Joyce Sanders, Tesa M. Severson, Elise M. Bekers, Maartje Alkemade, Hilda de Barros, Karianne Schuurman, Nils Eickhoff, Suzan Stelloo, Marlous Hoogstraat, Simon Linder
Supplementary Figure from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f42b86f8b15f67e1989e728942677f1
https://doi.org/10.1158/2159-8290.22541192
https://doi.org/10.1158/2159-8290.22541192
Autor:
Wilbert Zwart, Andries M. Bergman, Henk van der Poel, Nathan A. Lack, Lisa M. Butler, Lodewyk F.A. Wessels, Matthew L. Freedman, Amina Zoubeidi, Felix Y. Feng, René H. Medema, Maarten Altelaar, Bogdan Pasaniuc, Ji-Heui Seo, Claudia Giambartolomei, Iris de Rink, Roelof J.C. Kluin, Jeroen de Jong, Dorine C. Hintzen, Anniek Zaalberg, Martin Sjöström, Sylvan C. Baca, Yongsoo Kim, Liesbeth Hoekman, Umut Berkay Altintas, Tunc Morova, Chia-Chi Flora Huang, Joyce Sanders, Tesa M. Severson, Elise M. Bekers, Maartje Alkemade, Hilda de Barros, Karianne Schuurman, Nils Eickhoff, Suzan Stelloo, Marlous Hoogstraat, Simon Linder
In prostate cancer, androgen receptor (AR)–targeting agents are very effective in various disease stages. However, therapy resistance inevitably occurs, and little is known about how tumor cells adapt to bypass AR suppression. Here, we performed in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ac6a409e8171f21c2df0636766df70
https://doi.org/10.1158/2159-8290.c.6549566
https://doi.org/10.1158/2159-8290.c.6549566